← Eichor
Condition: Chronic Kidney Disease Stage 3 Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Chronic Kidney Disease Stage 3

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study of AND017 to Evaluate Efficacy and Safety in Patients With Anemia Due to Non-Dialysis-Dependent Chronic Kidney D
Phase 3 · 1 location(s) · Kind Pharmaceuticals LLC · NCT07487727Equol and Vascular Function in Women With Chronic Kidney Disease
Phase 2 · 1 location(s) · University of Colorado, Denver · NCT07194590Efficacy of Immunosuppressive Therapy for IgA Nephropathy With Stage 3 or 4 CKD
Phase 3 · 1 location(s) · Air Force Military Medical University, China · NCT05510323Intensification of Blood Pressure Lowering Therapeutics Based on Diuretics Versus Usual Management for Uncontrolled Hype
Phase 3 · 40 location(s) · University Hospital, Tours · NCT05732727Effects of Replacing High Protein Foods in People With Chronic Kidney Disease
NA · 1 location(s) · Indiana University · NCT07105670Closed-Loop Impact on Chronic Kidney Disease in Type 2 Diabetes
NA · 2 location(s) · Heba Al-Alwan · NCT06925217A Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatmen
Phase 3 · 21 location(s) · AMAG Pharmaceuticals, Inc. · NCT03619850ACE Reno, Pico Cell Matrix and Its Effect on eGFR in Chronic Kidney Diseases
Phase 4 · 1 location(s) · Ace Cells Lab Limited · NCT07187713Low-Protein Diet With Low-Protein Foods Versus a LPD Without LP Foods in Patients With Chronic Kidney Disease (CKD)
NA · 21 location(s) · Dr. Schär AG / SPA · NCT05489120A Study of AND017 to Evaluate Efficacy and Safety in Dialysis-Dependent Chronic Kidney Disease (DD-CKD) Patients With An
Phase 3 · 1 location(s) · Kind Pharmaceuticals LLC · NCT07494409Prediction of Peripheral Neuropathy With Functional Testing
Phase N/A · 1 location(s) · Université catholique de l'Ouest · NCT06933108AK+ Guard™ Pilot Study in Chronic Kidney Disease: Outpatient Diagnostic Accuracy and Remote Monitoring
Phase N/A · 1 location(s) · AccurKardia, Inc. · NCT07210021Phase 3 Clinical Trial with Dapagliflozin in Chronic Kidney Disease in Adolescents and Young Adult Patients
Phase 3 · 16 location(s) · University Hospital Goettingen · NCT05944016Study to Assess the Effects of Angiopoietin-like Protein 3 (ANGPTL3) Inhibition in Adult Participants With Diabetic Kidn
Phase 2 · 57 location(s) · Regeneron Pharmaceuticals · NCT07271186Vitamin K AntagonISt, Factor Xa Inhibitor or No Anticoagulation in Atrial Fibrillation and DIalytic End-stage Renal Dise
Phase 4 · 6 location(s) · Hospital Sirio-Libanes · NCT06402851A Study to Investigate the Safety, Tolerability, and Preliminary Efficacy With AION-301 Administered by Intravenous Infu
Phase 1/Phase 2 · 2 location(s) · AION Healthspan, Inc. · NCT06721143A Phase 3 Study of Efepoetin Alfa for Treatment of Anemia in Patients With Chronic Kidney Disease on Dialysis
Phase 3 · 58 location(s) · Genexine, Inc. · NCT06466785Exercise Activity to Improve Mobility in Patients With CKD and PAD
NA · 3 location(s) · University Hospital of Ferrara · NCT06621264Patiromer and Diet/hrQoL in Chronic Dialysis
Phase 3 · 1 location(s) · Mario Negri Institute for Pharmacological Research · NCT06858280A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and
Phase 3 · 568 location(s) · Eli Lilly and Company · NCT07241390A Trial of Etelcalcetide in Pediatric Participants With Secondary Hyperparathyroidism and Chronic Kidney Disease on Hemo
Phase 3 · 43 location(s) · Amgen · NCT03633708Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease
Phase 3 · 95 location(s) · Prokidney · NCT05099770A Study of Roxadustat to Treat Anemia in Children and Teenagers With Chronic Kidney Disease
Phase 3 · 47 location(s) · Astellas Pharma Global Development, Inc. · NCT05970172Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (
Phase 2/Phase 3 · 548 location(s) · CSL Behring · NCT05485961Evaluation of the Effect of a Daily Dose of Wakame Seaweed on Reducing Circulating Concentrations of Advanced Glycation
NA · 1 location(s) · Groupe Hospitalier de la Rochelle Ré Aunis · NCT07729683A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and China
Phase 3 · 42 location(s) · Alebund Pharmaceuticals · NCT06933472A Phase 3 Study of Etelcalcetide in Children With Secondary Hyperparathyroidism Receiving Hemodialysis
Phase 3 · 23 location(s) · Amgen · NCT03969329Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Phase N/A · 745 location(s) · Alliance for Clinical Trials in Oncology · NCT05334069Multimedia Health Education on Physical Fitness and Physical Activity for Patients With Chronic Kidney Disease
NA · 1 location(s) · Fu Jen Catholic University Hospital · NCT07493642Urinary Tubular Biomarkers for Chronic Kidney Disease
Phase N/A · 1 location(s) · Erasmus Medical Center · NCT06732349
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.